Embracing Digital Disruption in a Post-COVID World

Sponsored By:

Scott Snyder, Founder, Mobiquity and Senior Fellow, The Wharton School Celine Martin, Head of Digital Surgery, J&J Medical Devices James Kugler, CDO, Merck KGaA, Darmstadt, Germany Cris De Luca, Global Head, Digital Investments at Sanofi Ventures

Register now

Digital health took a huge technological step forward in 2020 due to the pandemic. Even traditionally less tech savvy people now rely on digital products and services to manage their own health including televisits, smart watches, online prescription refills, and connected fitness equipment. As we start to see the light at the end of the COVID tunnel, we’ll discuss how life sciences companies can embrace the acceleration in digital health and adapt their plans to capitalize on the growth opportunities it presents including transforming business and operating models.

What you will learn / key takeaways
• How COVID-19 has accelerated the adoption rate and expectations around digital health
• How to position your organization and operating model to get ahead of digital disruption
• Strategies and examples for driving disruption inside established life sciences companies
• What you can do as a leader to drive change

Who should attend:
Life Sciences and Healthcare leaders hoping to gain insights into how to accelerate their own digital transformation efforts through frameworks and examples discussed in the panel.

On Demand

About the Sponsors

Mobiquity is a digital consultancy that partners with the world’s leading brands to design and deliver compelling digital products and services. Our end-to-end services consider every dimension of a digital business from marketing to IT, providing strategy, experience design, product engineering, cloud services, and analytics.

For more information please visit https://www.mobiquity.com